Skip header and navigation

14 records – page 1 of 1.

Document Type
Table
Review Code
INF121501 RR Table
Question Submitted
December 15, 2020
Date Completed
December 17, 2020
Status
3. Completed
Research Team
Infectious Disease
Document Type
Table
Review Code
INF121501 RR Table
Question Submitted
December 15, 2020
Date Completed
December 17, 2020
Status
3. Completed
Research Team
Infectious Disease
Category
Epidemiology
Infection Prevention and Control
Subject
Transmission
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Vanstone, J; Miller, L; Fox, L. How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? 2020 Dec 17; Document no.: INF121501 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2020. (CEST table)
Related Documents
Documents

INF121501 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC031801v019 RR Table
Question Submitted
March 18, 2021
Date Completed
December 20, 2021
Status
5. Updated review
Research Team
EOC
Document Type
Table
Review Code
EOC031801v019 RR Table
Question Submitted
March 18, 2021
Date Completed
December 20, 2021
Status
5. Updated review
Research Team
EOC
Category
Epidemiology
Healthcare Services
Subject
Health Planning
Variants
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Asamoah, G; Badea, A; Hernandez-Ronquillo, L; Lee, S; Shumilak, G; Reeder, B; Groot, G; Muhajarine, N; Miller, L; Howell-Spooner, B. What is the epidemiology of variants and what are the implications for healthcare? 2021 Dec 20. Document no.: EOC031801v019 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST table).
Review History
EOC031801v18 RR
EOC031801v17 RR
EOC031801v16 RR
EOC031801v15 RR
EOC031801v14 RR
v012 and v013 RR were combined into v013
EOC031801v011 RR: August 27, 2021
v010 and v011 RR were combined into v011
EOC031801v9 RR: August 19, 2021
EOC031801v8 RR: July 12, 2021
EOC031801v7 RR; June 24, 2021
EOC031801v6 RR; June 17, 2021
EOC031801v5 RR; June 2, 2021
EOC031801v4 RR; May 17, 2021
EOC031801v3 RR: May 3, 2021
EOC031801v2 RR: April 20, 2021
EOC031801 RR: March 25, 2021
Related Documents
Documents

EOC031801v019 RR Table

Download File
Less detail
Document Type
Table
Review Code
INF031801v019 RR Table
Question Submitted
March 18, 2021
Date Completed
December 26, 2021
Status
5. Updated review
Research Team
Infectious Disease
Document Type
Table
Review Code
INF031801v019 RR Table
Question Submitted
March 18, 2021
Date Completed
December 26, 2021
Status
5. Updated review
Research Team
Infectious Disease
Category
Epidemiology
Infection Prevention and Control
Subject
Vaccines
Immunity
Infection Prevention and Control
Clinical Presentation
Population
All
Clinical Setting
Community
ICU
Medicine Unit
Primary care
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Jagwani, M; Lee, S; Shumilak, G; Reeder, B; Groot, G; Hernandez, L; Howell-Spooner, B; Miller, L. How effective are COVID-19 vaccines? 2021 Dec 26; Document no.: INF031801v019 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST Table)
Similar Reviews
EOC011901 RR
EOC031001 RR
Review History
INF031801v17 RR: November 23, 2021
INF031801v16 RR: November 12, 2021
INF031801v15 RR: October 28, 2021
INF031801v014 RR: October 16, 2021
INF031801v013 RR: September 24, 2021
INF031801v012 RR: September 10, 2021
INF031801v010 RR: August 25, 2021
INF031801v9 RR: August 23, 2021
INF031801v8 RR: August 9, 2021
INF031801v7 RR: July 20, 2021
INF031801v6 RR: July 2, 2021
INF031801v5 RR: June 22, 2021
INF031801v4 RR: June 3, 2021
INF031801v3 RR: May 24, 2021
INF031801v2 RR: May 14, 2021
INF031801 RR: March 31, 2021
Related Documents
Documents

INF031801v019 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC210302 RR Table
Question Submitted
March 30, 2021
Date Completed
April 21, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210302 RR Table
Question Submitted
March 30, 2021
Date Completed
April 21, 2021
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Healthcare Services
Subject
Vaccines
Vaccination
Risk
Comorbidities
Population
All
Other
vulnerable populations (clinically)
Clinical Setting
Cardiac unit
Community
Dialysis unit
ICU
Long Term Care
Medicine Unit
NICU
Oncology
Primary care
Public Health
Priority Level
Level 3 Two weeks (14 days)
Cite As
Azizian, A; Lee, S; Shumilak, G; Groot, G; Reeder, B; Miller, L; Howell-Spooner, B. What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? 2021 Apr 20, Document no.: EOC210302 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST table).
Similar Reviews
INF031801 RR
Related Documents
Documents

EOC210302 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC210503 RR Table
Question Submitted
May 28, 2021
Date Completed
June 21, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210503 RR Table
Question Submitted
May 28, 2021
Date Completed
June 21, 2021
Status
3. Completed
Research Team
EOC
Category
Administration
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Lashta E, von Tigerstrom B, Reeder B, Groot G; Miller, L; Mueller, M. What are the ethical/legal aspects of vaccine requirements? 2021 Jun 21, Document no.: EOC210503 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST Table).
Related Documents
Documents

EOC210503 RR Table

Download File
Less detail
Document Type
Table
Review Code
EPM210601v2 RR Table
Question Submitted
June 22, 2021
Date Completed
March 18, 2022
Status
3. Completed
Research Team
Epidemiology & Modelling
Document Type
Table
Review Code
EPM210601v2 RR Table
Question Submitted
June 22, 2021
Date Completed
March 18, 2022
Status
3. Completed
Research Team
Epidemiology & Modelling
Category
Clinical Presentation
Epidemiology
Subject
Long Covid
Symptoms
Clinical Presentation
Population
All
Clinical Setting
Ambulatory
Community
ICU
Long Term Care
Medicine Unit
Primary care
Public Health
Priority Level
Level 1 2-3 days
Cite As
Hammond, B; Badea, A; Groot, G; Reeder, B; Howell-Spooner, B; Mueller, M. What is the incidence and duration of long COVID cases? 2022 Mar 31, Document no.: EPM210601v2 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. CEST Table
Related Documents
Documents

EPM210601v2 RR Table

Download File
Less detail
Document Type
Table
Review Code
EPM210602v002 RR Table
Question Submitted
June 22, 2021
Date Completed
June 20, 2022
Status
5. Updated review
Research Team
Epidemiology & Modelling
Document Type
Table
Review Code
EPM210602v002 RR Table
Question Submitted
June 22, 2021
Date Completed
June 20, 2022
Status
5. Updated review
Research Team
Epidemiology & Modelling
Category
Clinical Presentation
Epidemiology
Subject
Long Covid
Health Planning
Clinical Presentation
Population
All
Clinical Setting
Ambulatory
Community
Emergency
ICU
Long Term Care
Medicine Unit
Primary care
Public Health
Priority Level
Level 1 2-3 days
Cite As
Groot, G; Reeder, B; Hammond, B; Badea, A; Howell-Spooner, B; Ellsworth, C. What are long COVID's demands on the healthcare system, and its severity of the illness? 2022 Jun 20, Document no.: EPM210602v002 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Related Documents
Documents

EPM210602v002 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC210902 RR Table
Question Submitted
September 22, 2021
Date Completed
October 7, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC210902 RR Table
Question Submitted
September 22, 2021
Date Completed
October 7, 2021
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Infection Prevention and Control
Subject
Decision Making
Health Planning
Infection Prevention and Control
Vaccination
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 3 Two weeks (14 days)
Related Documents
Documents

EOC210902 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC211220 RR Table
Question Submitted
December 20, 2021
Date Completed
December 22, 2021
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC211220 RR Table
Question Submitted
December 20, 2021
Date Completed
December 22, 2021
Status
3. Completed
Research Team
EOC
Category
Epidemiology
Healthcare Services
Subject
Variants
Health Planning
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 1 2-3 days
Cite As
Badea, A; Reeder, B; Groot, G; Miller, L. What is the epidemiology of the Omicron variant and its impact on health care? 2021 Dec 22, Document no.: EOC211220 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2021. (CEST table).
Related Documents
Documents

EOC211220 RR Table

Download File
Less detail
Document Type
Table
Review Code
CAC220101 RR Table
Question Submitted
January 11, 2022
Date Completed
February 10, 2022
Status
3. Completed
Research Team
Clinical/Acute Care
Document Type
Table
Review Code
CAC220101 RR Table
Question Submitted
January 11, 2022
Date Completed
February 10, 2022
Status
3. Completed
Research Team
Clinical/Acute Care
Category
Administration
Healthcare Services
Subject
Decision Making
Health Planning
Hospitalization
Population
All
Clinical Setting
Ambulatory
Cardiac unit
Community
Dialysis unit
Emergency
EMS
ICU
Long Term Care
Medicine Unit
NICU
Oncology
Primary care
Public Health
Other
Priority Level
Level 2 One week (7 days)
Cite As
Asamoah, G; Badea, A; Reeder, B; Groot, G; Muhajarine, N; Howell-Spooner, B; Young, C. What is the (case) definition of hospitalization for COVID-19 in similar jurisdictions? 2022 Feb 10. Document no.: CAC220101 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST Table).
Related Documents
Documents

CAC220101 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC220302 RR Table
Question Submitted
March 1, 2022
Date Completed
March 10, 2022
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC220302 RR Table
Question Submitted
March 1, 2022
Date Completed
March 10, 2022
Status
3. Completed
Research Team
EOC
Category
Clinical Management
Infection Prevention and Control
Subject
Infection Prevention and Control
Immunity
Risk
Vaccines
Population
All
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 2 One week (7 days)
Cite As
Badea, A; Groot, G; Reeder, B; Miller, L. What is the safety/efficacy of the Novavax COVID-19 vaccine? 2022 Mar 10. Document no.: EOC220302 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. 8 p. (CEST Table)
Related Documents
Documents

EOC220302 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC220304v002 RR Table
Question Submitted
March 29, 2022
Date Completed
June 7, 0222
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC220304v002 RR Table
Question Submitted
March 29, 2022
Date Completed
June 7, 0222
Status
3. Completed
Research Team
EOC
Category
Healthcare Services
Infection Prevention and Control
Subject
Clinical Presentation
Immunity
Infection Prevention and Control
Vaccines
Population
All
Clinical Setting
Community
Primary care
Public Health
Priority Level
Level 1 2-3 days
Cite As
Badea, A; Groot, G; Reeder, B; Dalidowicz, M; Howell-Spooner, B. What is the efficacy of a 4th booster dose for COVID-19? 2022 Jun 7. Document no.: EOC220304v002 RR Table. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Similar Reviews
INF031801v020 ESR
INF031801v019 RR
Related Documents
Documents

EOC220304v002 RR Table

Download File
Less detail
Document Type
Table
Review Code
EOC211220v016 ESR Table
Question Submitted
December 20, 2021
Date Completed
April 14, 2022
Status
3. Completed
Research Team
EOC
Document Type
Table
Review Code
EOC211220v016 ESR Table
Question Submitted
December 20, 2021
Date Completed
April 14, 2022
Status
3. Completed
Research Team
EOC
Key Findings
Mueller, M; Miller, L. What is the epidemiology of the Omicron variant and its impact on health care? 2022 Apr 14. Document no.: EOC211220v016 ESR. In: COVID-19 Rapid Evidence Reviews [Internet].SK: SK COVID Evidence Support Team, c2022. (CEST table).
Category
Epidemiology
Healthcare Services
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 1 2-3 days
Related Documents
Documents

EOC211220v016 ESR Table

Download File
Less detail
Document Type
Table
Review Code
INF220501 RR Table
Question Submitted
May 16, 2022
Date Completed
June 6, 2022
Status
3. Completed
Research Team
Infectious Disease
Document Type
Table
Review Code
INF220501 RR Table
Question Submitted
May 16, 2022
Date Completed
June 6, 2022
Status
3. Completed
Research Team
Infectious Disease
Category
Clinical Presentation
Diagnostics
Subject
Immunity
Infection Prevention and Control
Vaccination
Population
All
Clinical Setting
Community
Public Health
Priority Level
Level 4 Three weeks (21 days)
Cite As
Groot, G; Reeder, B; Muhajarine, N; Lee, S; Badea, A; Fox, L; Miller, L. What is known about hybrid immunity to COVID-19? 2022 Jun 06, Document no.: INF220501 RR. In: COVID-19 Rapid Evidence Reviews [Internet]. SK: SK COVID Evidence Support Team, c2022. (CEST table).
Related Documents
Documents

INF220501 RR Table

Download File
Less detail

14 records – page 1 of 1.